Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

被引：0
作者：
Anna Rydén
Fiona Blackhall
Hye Ryun Kim
Rathi N. Pillai
Lauren Braam
Mona L. Martin
Andrew Walding
机构：
[1] AstraZeneca Gothenburg,Division of Molecular and Clinical Cancer Sciences
[2] University of Manchester,Department of Medical Oncology, Yonsei Cancer Center
[3] The Christie NHS Foundation Trust,Department of Hematology and Medical Oncology, School of Medicine
[4] Yonsei University College of Medicine,undefined
[5] Winship Cancer Institute of Emory University,undefined
[6] Health Research Associates Inc.,undefined
[7] AstraZeneca R&D,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2017年 / 10卷
关键词：
Epidermal Growth Factor Receptor; Initial Interview; Poor Appetite; Bothersome Symptom; Transcript Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：593 / 603
页数：10
相关论文
共 50 条
[21]   Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial [J].
Akamatsu, Hiroaki ;
Katakami, Nobuyuki ;
Okamoto, Isamu ;
Kato, Terufumi ;
Kim, Young Hak ;
Imamura, Fumio ;
Shinkai, Masaharu ;
Hodge, Rachel A. ;
Uchida, Hirohiko ;
Hida, Toyoaki .
CANCER SCIENCE, 2018, 109 (06) :1930-1938
[22]   Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer [J].
Karaca, Halit ;
Geredeli, Caglayan ;
Kaplan, M. Ali ;
Demirci, Umut ;
Alici, Suleyman ;
Artac, Mehmet ;
Isikdogan, Abdurrahman ;
Benekli, Mustafa ;
Balakan, Ozan ;
Arpaci, Erkan ;
Budakoglu, Burcin ;
Uncu, Dogan ;
Guler, Tunc ;
Berk, Veil ;
Ozkan, Metin .
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (01) :1-6
[23]   Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib [J].
Hirsch, F. R. ;
Varella-Garcia, M. ;
Cappuzzo, F. ;
McCoy, J. ;
Bemis, L. ;
Xavier, A. C. ;
Dziadziuszko, R. ;
Gumerlock, P. ;
Chansky, K. ;
West, H. ;
Gazdar, A. F. ;
Crino, L. ;
Gandara, D. R. ;
Franklin, W. A. ;
Bunn, P. A., Jr. .
ANNALS OF ONCOLOGY, 2007, 18 (04) :752-760
[24]   QT interval prolongation related to afatinib treatment in a patient with metastatic non-small-cell lung cancer [J].
Demircan, Nazim Can ;
Telli, Tugba Akin ;
Tuylu, Tugba Basoglu ;
Arikan, Rukiye ;
Kocakaya, Derya ;
Sahin, Ahmet Anil ;
Ercelep, Ozlem ;
Dane, Faysal ;
Yumuk, Perran Fulden .
CURRENT PROBLEMS IN CANCER, 2020, 44 (06)
[25]   Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how? [J].
Juergens R. ;
Brahmer J. .
Current Oncology Reports, 2007, 9 (4) :255-264
[26]   Osimertinib in the Treatment of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: A Meta-Analysis [J].
Pan, Jie ;
Cai, Xiaoping ;
Cao, Zhuo ;
Pan, Jiongwei ;
Zheng, Hao .
PHARMACOLOGY, 2023, 108 (01) :8-16
[27]   Smoking History as a Predictive Factor of Treatment Response in Advanced Non-Small-Cell Lung Cancer: A Systematic Review [J].
Mitchell, Paul ;
Mok, Tony ;
Barraclough, Helen ;
Strizek, Alena ;
Lew, Rebecca ;
van Kooten, Maximiliano .
CLINICAL LUNG CANCER, 2012, 13 (04) :239-251
[28]   First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer [J].
Yin Y.-M. ;
Geng Y.-T. ;
Shao Y.-F. ;
Hu X.-L. ;
Li W. ;
Shu Y.-Q. ;
Wang Z.-X. .
Journal of Experimental & Clinical Cancer Research, 29 (1)
[29]   Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer [J].
Zhou, Songwen ;
Ren, Shengxiang ;
Yan, Lianghua ;
Zhang, Ling ;
Tang, Liang ;
Zhang, Jie ;
Zhou, Caicun .
RESPIROLOGY, 2009, 14 (05) :709-715
[30]   Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience [J].
Ulivi, Paola ;
Petracci, Elisabetta ;
Canale, Matteo ;
Priano, Ilaria ;
Capelli, Laura ;
Calistri, Daniele ;
Chiadini, Elisa ;
Cravero, Paola ;
Rossi, Alice ;
Delmonte, Angelo ;
Crino, Lucio ;
Bronte, Giuseppe .
BIOMEDICINES, 2021, 9 (10)
12345